Ensuring Black Lives Matter in Drug Development
Crossref DOI link: https://doi.org/10.1007/s43441-020-00232-1
Published Online: 2020-10-22
Published Print: 2021-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fitzsimmons, William E.
Okorie-Awé, Clara
Text and Data Mining valid from 2020-10-22
Version of Record valid from 2020-10-22
Article History
Received: 1 August 2020
Accepted: 9 October 2020
First Online: 22 October 2020
Compliance with Ethical Standards
:
: The authors have no financial interest in relation to this Letter.